Search

Your search keyword '"Lesiak, M."' showing total 724 results

Search Constraints

Start Over You searched for: Author "Lesiak, M." Remove constraint Author: "Lesiak, M."
724 results on '"Lesiak, M."'

Search Results

1. Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure

2. Upper limits for a narrow resonance in the reaction p + p -> K^+ + (Lambda p)

3. Study of the $\bm{p+^6}$Li$\bm{\to\eta+^7}$Be reaction 11.3 MeV above threshold

4. Cross section of the $pp\to K^+\Sigma^+n$ reaction close to threshold

5. High resolution study of the Lambda p final state interaction in the reaction p + p -> K+ + (Lambda p)

6. Cross sections of the $pp\to K^+\Sigma^+n$ reaction close to threshold

7. Precision measurements of the pp\to \pi^+pn and pp\to \pi^+d reactions: importance of long-range and tensor force effects

8. Cross Section and Tensor Analysing Power of the $\vec{d}d\to \eta\alpha$ Reaction Near Threshold

9. A large acceptance scintillator detector with wavelength shifting fibre read-out for search of eta-nucleus bound states

10. Measurement of the Vector and Tensor Polarisation of Proton and Deuteron Beams

11. A precision determination of the mass of the $\eta$ meson

14. Evidence-based Guidelines for the Management of Abnormally Invasive Placenta: Recommendations From the International Society for Abnormally Invasive Placenta

17. Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: Predictors of Procedural Success From the ERCTO Registry

19. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial

20. Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial

21. EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)

24. Gender distribution in patients treated with rotablation – analysis of 5,177 percutaneous coronary interventions based on a large national registry from between 2014 and 2020

25. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta

27. Posters display III clinical outcome and PET

28. The impact of chemotheraphy and supervised high-intensity interval physical activity on left ventricle strain and myocardial work parameters – SPORT NATHY TRIAL pilot study results

30. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

31. 192P Strategies and results of oncofertility counselling in young breast cancer patients

32. Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European society of cardiology guidelines

33. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

35. Posters display III clinical outcome and PET

37. 278Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with three-vessel disease: 3-year follow-up of the SYNTAX II study

39. Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study

40. Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study

41. Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions

42. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy

43. Intraadrenal Dendritic Cells and Macrophages Inhibit Corticosterone Response during Collagen-induced Arthritis – a Role for IL-1β and CXC chemokines?

45. P2693The long-term impact of post-procedural asymmetry and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial

48. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy

49. Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry

50. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry

Catalog

Books, media, physical & digital resources